U.S. flag An official website of the United States government
  1. Home
  2. Vaccines, Blood & Biologics
  3. Vaccines
  4. Pediarix
  1. Vaccines

STN: BL 103907
Proper Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined
Tradename: Pediarix
Manufacturer: GlaxoSmithKline Biologicals
Indications:

  • For active immunization against diphtheria, tetanus, pertussis, infection caused by all known subtypes of hepatitis B virus, and poliomyelitis. PEDIARIX is approved for use as a three-dose series in infants born of hepatitis B surface antigen (HBsAg)-negative mothers. PEDIARIX may be given as early as 6 weeks of age through 6 years of age (prior to the 7th birthday).

Product Information

Supporting Information